Jorge Lima։ Understanding Recurrent Pregnancy Loss
Jorge Lima, Professor Auxiliar Convidado at NOVA Medical School, Gynecologist and Obstetrician at Hospital da Luz Lisbon, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
”Now published: Systematic review and meta-analysis on recurrent pregnancy loss (RPL)
I’m pleased to share our recent publication examining the overall prevalence of recurrent pregnancy loss and the distribution of its major etiological categories.
Despite its clinical and emotional impact, robust data on how common RPL truly is, and how its causes are distributed, have remained surprisingly limited and heterogeneous.
In this systematic review and meta-analysis of 105 studies and nearly 48,000 women with RPL:
- The estimated population-based prevalence of RPL was approximately 1%, although based on very limited data
- The largest proportion of cases remains unexplained (37%)
Other major categories included:
- Acquired thrombophilia (12%)
- Endocrine factors (8%)
- Anatomical factors and hereditary thrombophilia (6%)
Our findings highlight substantial between-study heterogeneity, partly driven by geographic, demographic, and temporal factors.
Importantly, this work underscores a key issue in reproductive medicine:
- A significant proportion of RPL cases still lack a clear etiological explanation
- There is an urgent need for standardized definitions, diagnostic approaches, and reporting frameworks
To our knowledge, this is among the first meta-analytical syntheses focusing specifically on the prevalence of RPL alongside its etiological distribution, addressing a major gap in the literature.”
Title: Recurrent pregnancy loss: systematic review and meta-analysis of overall prevalence and the distribution of major etiological categories
Authors: Tiago Carvalho, Miguel Ângelo-Dias, Filipa Moutinho, Sofia Silvério Serra, Teresa Costa, João Paulo Martins, Gonçalo S. Duarte, Jorge Lima
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 14, 2026, 17:24EHC ERIN Webinar on Fibrinogen Disorders
-
Oct 14, 2026, 16:50Peter Kouides: The Role of Multidisciplinary Networks in Women’s Hematologic Care
-
Oct 14, 2026, 16:35Thaís Leonel: Analytical Consistency as a Foundation for Evidence-Based Thrombosis Management
-
Oct 14, 2026, 16:28Christina Yiangou: Presenting the HemaFAIR Project at ASCAT 2026 in London
-
Oct 14, 2026, 16:27ITP Research and the Importance of Patient Involvement – ITP Australia and New Zealand
-
Oct 14, 2026, 16:19Ganesh Mohan: Complexities of Thrombosis Care Across Diverse Patient Populations
-
Oct 14, 2026, 16:17Louise St. Germain Bannon: Every Conversation Matters Beyond World Thrombosis Day
-
Oct 14, 2026, 16:11Christina Pierre: A Life-Course Approach to Thrombosis Risk in Women
-
Oct 14, 2026, 16:06Belinda Minnaar: Recognizing Leadership in VTE Prevention on World Thrombosis Day